Browse > Article
http://dx.doi.org/10.7314/APJCP.2013.14.11.6821

Soft-tissue Sarcomas in the Asia-Pacific Region: A Systematic Review  

Ngan, Roger (Department of Clinical Oncology, Queen Elizabeth Hospital)
Wang, Edward (Department of Orthopaedics, University of the Philippines, Philippine General Hospital)
Porter, David (Medical Oncology, Auckland Regional Cancer and Blood Service)
Desai, Jayesh (Department of Medical Oncology, Royal Melbourne Hospital)
Prayogo, Nugroho (Department of Medical Oncology, Dharmais Hospital National Cancer Center)
Devi, Beena (Department of Radiotherapy, Oncology and Palliative Care, Sarawak General Hospital)
Quek, Richard (Department of Medical Oncology, National Cancer Centre)
Publication Information
Asian Pacific Journal of Cancer Prevention / v.14, no.11, 2013 , pp. 6821-6832 More about this Journal
Abstract
Background: Soft-tissue sarcomas require tailored and multidisciplinary treatment and management. However, little is known about how sarcomas are treated and managed throughout the Asia-Pacific region. Materials and Methods: MEDLINE was systematically searched using prespecified criteria. Publications (previous 10 years) that reported tumour characteristics, treatment patterns, survival outcomes, and/or safety outcomes of patients with soft-tissue sarcoma were selected. Exclusion criteria were studies of patients <18 years of age; ${\leq}10$ patients; countries other than Australia, Hong Kong, Indonesia, Korea, Malaysia, New Zealand, Philippines, Singapore, Taiwan, or Thailand; >20% benign tumours; sarcomas located in bones or joints; gastrointestinal stromal tumour; Kaposi's sarcoma; or not reporting relevant outcomes. Results: Of the 1,822 publications retrieved, 35 (32 studies) were included. Nearly all patients (98%, 1,992/2,024; 31 studies) were treated with surgery, and more studies used adjuvant radiotherapy than chemotherapy (24 vs 17 studies). Survival outcomes and recurrence rates varied among the studies because of the different histotypes, sites, and disease stages assessed. Only 5 studies reported safety findings. Conclusions: These findings highlight the lack of specific data available about soft-tissue sarcomas in the Asia-Pacific region. Better efforts to understand how the sarcoma is managed and treated will help improve patient outcomes in the region.
Keywords
Asia-Pacific; incidence; sarcoma; soft-tissue neoplasms; survival;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Acuin J, Firestone R, Htay TT, et al (2011). Southeast Asia: an emerging focus for global health. Lancet, 377, 534-5.   DOI   ScienceOn
2 An JY, Heo JS, Noh JH, et al (2007). Primary malignant retroperitoneal tumors: analysis of a single institutional experience. Eur J Surg Oncol, 33, 376-82.   DOI   ScienceOn
3 Campbell C, Gallagher J, Dickinson I (2004). Synovial sarcoma--towards a simplified approach to prognosis. ANZ J Surg, 74, 727-31.   DOI   ScienceOn
4 Casali PG, Blay JY, ESMO/CONTICANET/EUROBONET Consensus Panel of experts (2010). Soft tissue sarcomas: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol, 21, 198-203.   DOI   ScienceOn
5 Chan CY, Janarthan N, Vivek AS, Jayalakshmi P (2008). The outcome of pleomorphic sarcoma at University Malaya Medical Center--a fifteen-year review. Med J Malaysia, 63, 311-4.
6 Cho SY, Moon KC, Cheong MS, et al (2011). Significance of microscopic margin status in completely resected retroperitoneal sarcoma. J Urol, 186, 59-65.   DOI   ScienceOn
7 Chongsuvivatwong V, Phua KH, Yap MT, et al (2011). Health and health-care systems in southeast Asia: diversity and transitions. Lancet, 377, 429-37.   DOI   ScienceOn
8 Choong PF, Nizam I, Ngan SY, et al (2003). Thallium-201 scintigraphy--a predictor of tumour necrosis in soft tissue sarcoma following preoperative radiotherapy? Eur J Surg Oncol, 29, 908-15.   DOI   ScienceOn
9 Clark MA, Fisher C, Judson I, Thomas JM (2005). Soft-tissue sarcomas in adults. N Engl J Med, 353, 701-11.   DOI   ScienceOn
10 Colombo C, Randall RL, Andtbacka RH, Gronchi A (2012). Surgery in soft tissue sarcoma: more conservative in extremities, more extended in the retroperitoneum. Expert Rev Anticancer Ther, 12, 1079-87.   DOI   ScienceOn
11 Dickinson IC, Whitwell DJ, Battistuta D, et al (2006). Surgical margin and its influence on survival in soft tissue sarcoma. ANZ J Surg, 76, 104-9.   DOI
12 Gronchi A, Miceli R, Colombo C, et al (2011). Primary extremity soft tissue sarcomas: outcome improvement over time at a single institution. Ann Oncol, 22, 1675-81.   DOI   ScienceOn
13 Fletcher C, Rydholm A, Singer S, Sundaram M, Coindre J (2002a). Soft tissue tumours: Epidemiology, clinical features, histopathological typing and grading. In Fletcher C, Unni K,Mertens F (eds): Pathology and genetics of tumours of soft tissue and bone. Lyon, France; IARC Press, International Agency for Research on Cancer, 12-8.
14 Fletcher C, Unni K, Mertens F (2002b). Pathology and Genetics of Tumours of Soft Tissue and Bone. Lyon, France; IARC Press, International Agency for Research on Cancer.
15 Gronchi A, Casali PG, Mariani L, et al (2005). Status of surgical margins and prognosis in adult soft tissue sarcomas of the extremities: a series of patients treated at a single institution. J Clin Oncol, 23, 96-104.   DOI   ScienceOn
16 Han I, Kang HG, Kang SC, Choi JR, Kim HS (2011). Does delayed reexcision affect outcome after unplanned excision for soft tissue sarcoma? Clin Orthop Relat Res, 469, 877-83.   DOI
17 Hong SH, Kim KA, Woo OH, et al (2010). Dedifferentiated liposarcoma of retroperitoneum: spectrum of imaging findings in 15 patients. Clin Imaging, 34, 203-10.   DOI   ScienceOn
18 Hsieh CH, Lin H, Huang CC, et al (2003). Leiomyosarcoma of the uterus: a clinicopathologic study of 21 cases. Acta Obstet Gynecol Scand, 82, 74-81.   DOI   ScienceOn
19 Hsu HC, Huang EY, Wang CJ (2004). Treatment results and prognostic factors in patients with malignant fibrous histiocytoma. Acta Oncol, 43, 530-5.   DOI   ScienceOn
20 Huang HY, Kang HY, Li CF, et al (2006). Skp2 overexpression is highly representative of intrinsic biological aggressiveness and independently associated with poor prognosis in primary localized myxofibrosarcomas. Clin Cancer Res, 12, 487-98.   DOI   ScienceOn
21 Huang HY, Huang WW, Wu JM, et al (2008). Flow cytometric analysis of DNA ploidy and S-phase fraction in primary localized myxofibrosarcoma: correlations with clinicopathological factors, Skp2 expression, and patient survival. Ann Surg Oncol, 15, 2239-49.   DOI
22 Huang HY, Li CF, Fang FM, et al (2010). Prognostic implication of ezrin overexpression in myxofibrosarcomas. Ann Surg Oncol, 17, 3212-9.   DOI
23 Hui AC, Ngan SY, Wong K, Powell G, Choong PF (2006). Preoperative radiotherapy for soft tissue sarcoma: the Peter MacCallum Cancer Centre experience. Eur J Surg Oncol, 32, 1159-64.   DOI   ScienceOn
24 Jun HJ, Lee J, Lim do H, et al (2010). Expression of MET in alveolar soft part sarcoma. Med Oncol, 27, 459-65.   DOI   ScienceOn
25 Kiatisevi P, Asavamongkolkul A, Phimolsarnti R, Waikakul S, Benjarassamerote S (2006). The outcomes and prognostic factors of patients with soft-tissue sarcoma. J Med Assoc Thai, 89, 334-42.
26 Kim EY, Kim SJ, Choi D, et al (2008a). Recurrence of retroperitoneal liposarcoma: imaging findings and growth rates at follow-up CT. AJR Am J Roentgenol, 191, 1841-6.   DOI   ScienceOn
27 Kim HS, Lee J, Yi SY, et al (2009). Liposarcoma: exploration of clinical prognostic factors for risk based stratification of therapy. BMC Cancer, 9, 205.   DOI   ScienceOn
28 Kim WY, Lee JW, Choi CH, et al (2008b). Low-grade endometrial stromal sarcoma: a single center’s experience with 22 cases. Int J Gynecol Cancer, 18, 1084-9.   DOI   ScienceOn
29 Kim HS, Han KH, Chung HH, et al (2010). Neutrophil to lymphocyte ratio for preoperative diagnosis of uterine sarcomas: a case-matched comparison. Eur J Surg Oncol, 36, 691-8.   DOI   ScienceOn
30 Kim MS, Cho WH, Song WS, Lee SY, Jeon DG (2007). Prognostic significance of ezrin expression in pleomorphic malignant fibrous histiocytoma. Anticancer Res, 27, 1171-8.
31 Kim YB, Shin KH, Seong J, et al (2008c). Clinical significance of margin status in postoperative radiotherapy for extremity and truncal soft-tissue sarcoma. Int J Radiat Oncol Biol Phys, 70, 139-44.   DOI   ScienceOn
32 Koh KH, Cho EY, Kim DW, Seo SW (2009). Multivariate analysis of prognostic factors in synovial sarcoma. Orthopedics, 32, 824.
33 Lee SY, Goh BK, Teo MC, et al (2011). Retroperitoneal liposarcomas: the experience of a tertiary Asian center. World J Surg Oncol, 9, 12.   DOI   ScienceOn
34 Lin CN, Chou SC, Li CF, et al (2006). Prognostic factors of myxofibrosarcomas: implications of margin status, tumor necrosis, and mitotic rate on survival. J Surg Oncol, 93, 294-303.   DOI   ScienceOn
35 Liu CY, Yen CC, Chen WM, et al (2010). Soft tissue sarcoma of extremities: the prognostic significance of adequate surgical margins in primary operation and reoperation after recurrence. Ann Surg Oncol, 17, 2102-11.   DOI   ScienceOn
36 Luis AM, Aguilar DP, Martin JA (2010). Multidisciplinary management of soft tissue sarcomas. Clin Transl Oncol, 12, 543-53.   DOI
37 National Comprehensive Cancer Network (2012). NCCN Clinical Practice Guidelines in Oncology. Soft Tissue Sarcoma.
38 Mankin HJ, Hornicek FJ (2005). Diagnosis, classification, and management of soft tissue sarcomas. Cancer Control, 12, 5-21.
39 Miki Y, Ngan S, Clark JC, Akiyama T, Choong PF (2010). The significance of size change of soft tissue sarcoma during preoperative radiotherapy. Eur J Surg Oncol, 36, 678-83.   DOI   ScienceOn
40 Moncrieff MD, Kroon HM, Kam PC, et al (2008). Isolated limb infusion for advanced soft tissue sarcoma of the extremity. Ann Surg Oncol, 15, 2749-56.   DOI
41 Ng YC, Tan MH (2009). Liposarcoma of the extremities: a review of the cases seen and managed in a major tertiary hospital in Singapore. Singapore Med J, 50, 857-61.
42 Park JH, Kang CH, Kim CH, Chae IJ (2010). Highly malignant soft tissue sarcoma of the extremity with a delayed diagnosis. World J Surg Oncol, 8, 84.   DOI   ScienceOn
43 Pervaiz N, Colterjohn N, Farrokhyar F, et al (2008). A systematic meta-analysis of randomized controlled trials of adjuvant chemotherapy for localized resectable soft-tissue sarcoma. Cancer, 113, 573-81.   DOI   ScienceOn
44 Pisters PW, Leung DH, Woodruff J, Shi W, Brennan MF (1996). Analysis of prognostic factors in 1,041 patients with localized soft tissue sarcomas of the extremities. J Clin Oncol, 14, 1679-89.   DOI
45 Pisters PW, O'Sullivan B, Maki RG (2007). Evidence-based recommendations for local therapy for soft tissue sarcomas. J Clin Oncol, 25, 1003-8.   DOI   ScienceOn
46 Singer S, Corson JM, Gonin R, Labow B, Eberlein TJ (1994). Prognostic factors predictive of survival and local recurrence for extremity soft tissue sarcoma. Ann Surg, 219, 165-73.   DOI
47 Ray-Coquard I, Thiesse P, Ranchere-Vince D, et al (2004). Conformity to clinical practice guidelines, multidisciplinary management and outcome of treatment for soft tissue sarcomas. Ann Oncol, 15, 307-15.   DOI   ScienceOn
48 Rudiger HA, Ngan SY, Choong PF (2009). Surgical outcome of soft tissue sarcomas of the adductor compartment. J Orthop Surg (Hong Kong), 17, 284-7.   DOI
49 Sankaranarayanan R, Swaminathan R (2011). Cancer Survival in Africa, Asia, the Caribbean and Central America. Lyon, France; International Agency for Research on Cancer.
50 Singer S, Demetri GD, Baldini EH, Fletcher CD (2000). Management of soft-tissue sarcomas: an overview and update. Lancet Oncol, 1, 75-85.   DOI   ScienceOn
51 Stojadinovic A, Leung DH, Hoos A, et al (2002). Analysis of the prognostic significance of microscopic margins in 2,084 localized primary adult soft tissue sarcomas. Ann Surg, 235, 424-34.   DOI   ScienceOn
52 Wang CP, Chang YL, Ting LL, et al (2009). Malignant fibrous histiocytoma of the sinonasal tract. Head Neck, 31, 85-93.   DOI   ScienceOn
53 Wang L, Tan MH (2010). The natural history and prognosticative factors of adult extremity soft tissue sarcomas: an Asian perspective. Ann Acad Med Singapore, 39, 771-7.
54 Woll PJ, Reichardt P, Le Cesne A, et al (2012). Adjuvant chemotherapy with doxorubicin, ifosfamide, and lenograstim for resected soft-tissue sarcoma (EORTC 62931): a multicentre randomised controlled trial. Lancet Oncol, 13, 1045-54.   DOI
55 Wu TI, Chang TC, Hsueh S, et al (2006). Prognostic factors and impact of adjuvant chemotherapy for uterine leiomyosarcoma. Gynecol Oncol, 100, 166-72.   DOI   ScienceOn
56 Wong CK, Lam YL, So YC, Ngan KC, Wong KY (2004). Management of extremity soft tissue sarcoma after unplanned incomplete resection: experience of a regional musculoskeletal tumour centre. Hong Kong Med J, 10, 117-22.